These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8382163)

  • 1. Expression of human minor histocompatibility antigen on cultured kidney cells.
    Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
    Eur J Immunol; 1993 Feb; 23(2):467-72. PubMed ID: 8382163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
    Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
    Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of human minor histocompatibility peptides.
    Sekimata M; Griem P; Egawa K; Rammensee HG; Takiguchi M
    Int Immunol; 1992 Feb; 4(2):301-4. PubMed ID: 1622900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
    De Bueger M; Bakker A; Van Rood JJ; Goulmy E
    Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the conserved residue in pocket A and the polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells.
    Takiguchi M; Kawaguchi G; Sekimata M; Hiraiwa M; Kariyone A; Takamiya Y
    Int Immunol; 1994 Sep; 6(9):1345-52. PubMed ID: 7819142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
    de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
    J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
    Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
    Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
    Yamamoto J; Kariyone A; Akiyama N; Kano K; Takiguchi M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2583-7. PubMed ID: 2157206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of human minor histocompatibility peptides from cultured kidney cells.
    Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):162-6. PubMed ID: 8382382
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
    Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
    J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.
    Dolstra H; Fredrix H; Preijers F; Goulmy E; Figdor CG; de Witte TM; van de Wiel-van Kemenade E
    J Immunol; 1997 Jan; 158(2):560-5. PubMed ID: 8992968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.
    Yoshino I; Peoples GE; Goedegebuure PS; Maziarz R; Eberlein TJ
    J Immunol; 1994 Mar; 152(5):2393-400. PubMed ID: 8133050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
    Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
    Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.